Summary
SYDNEY Telix Pharmaceuticals Ltd (ASX: TLX) led the S&P/ASX 200 gainers Friday with a 3.23 percent surge to $14.08 after the U.S. Food and Drug Administration accepted its resubmitted New Drug Application for TLX101-Px (Pixclara), an investigational PET ima
Source: Ibtimes.com.au
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
